Pharmacogenomic analysis of low-density lipoprotein receptor 3' untranslated region genetic variants influencing rosuvastatin efficacy in Chinese dyslipidemia patients.

Pharmacogenet Genomics · 2025 · PMC12456195 · PMID 40910988

Europe PMC DOI

hedged sentence

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

borderline significanceP = 0.055so close (0.05 < p ≤ 0.1)

Although the association of the rs55903358 C allele with diminished TC-lowering efficacy was NS, it approached borderline significance ( P = 0.055; Table 3 and Fig. 4 b).

also in 4,964 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.